Explore practical strategies for designing fit-for-purpose ADC assays covering internalization, cytotoxicity, bystander killing, and serum/plasma stability. Learn how these assays help characterize MOA and efficacy, differentiate ADC candidates, and generate insights to predict in vivo performance.
In Vitro Assays for ADC Discovery: From Design to Translational Insights
30 September, 2026
Watch this next
Panel Discussion: Mastering Stability & Characterisation: Building Confidence In Protein & Antibody Therapeutics From Bench To Batch
Christian Hunzinger
BioNTech
Fabio Centola
Merck KGaA
Dennis Ungan
Novartis
Market Insight
Jul, 2026
Panel Discussion: Next-Generation Biomed: AI, Science, Or The People Behind – What Will Actually Scale?
Russell Lamontagne
Boston Immune Technologies
Yashas Kannan
PentaBind
Catherine Stace
Kuano
Market Insight
Jul, 2026
Panel Discussion: Next-Generation Modalities & Biotherapeutics: From Idea To Implementation
Miguel Gaspar
AstraZeneca
Steve Hood
GSK
Christopher Herring
T-Therapeutics
Michelle Barnard
ValiRx
Jennifer Mataraza
Novartis
Market Insight
Jul, 2026
You're just a click away
To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use
By rejecting you won't be able to progress to the LifeScienceXchange platform.







